Tag: Clinical Trials
Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectiveness
Eli Lilly says government is continuing a separate study testing the antibody drug in mild to moderately ill patients
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
U.S. Food and Drug Administration authorized the restart after reviewing all safety data
U.S. COVID-19 Vaccine Trial Enrolls 30,000
Moderna says it is on track to apply for FDA approval to market the vaccine in early December
Investigational Drug May Prolong Survival in Patients With ALS
Median survival 6.5 months longer with initiation of PB-TURSO treatment compared with placebo
Scientists to Infect Volunteers With COVID-19 in Challenge Trial
Challenge trials have long history, going back to development of smallpox vaccine in 1796
Upadacitinib Tops Abatacept for RA Refractory to DMARDs
Superior for mean change in composite DAS28-CRP values and remission, but more adverse events seen
Pharmacotherapy, Psychotherapy Combo Best for Bipolar Disorder
Manualized treatments linked to significantly reduced recurrence rates versus control treatments
Ertugliflozin Noninferior for CV Outcomes in T2DM With ASCVD
Ertugliflozin is noninferior to placebo for the primary end point of major adverse cardiovascular events
NIH Launches Trial of Antibody Drugs Against COVID-19
The phase 2 trial will assess effectiveness of monoclonal antibodies in conjunction with remdesivir
COVID-19 Antibody Treatment Study Paused
ACTIV-3 study, testing use of an antibody therapy with remdesivir, paused 'out of an abundance of caution'
